Health

India’s Covaxin Found To Offer 77.8 Percent Protection Against COVID-19: Study

GENEVA, Nov 12 — Data from Phase 3 trials of the coronavirus vaccine Covaxin, developed in India, has shown that two doses offer 77.8 per cent protection against COVID-19, according to findings published Thursday in The Lancet medical journal.

Covaxin, known by the code BBV152, is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology.

The drug on Nov 3 was granted emergency use approval by the World Health Organisation (WHO) for adults 18 years and older and is the eighth jab to be given the green light by the health body.

The WHO determined that Covaxin met its standards for protection against COVID-19 and “that the benefit of the vaccine far outweighs risks.”

It recommended the vaccine be administered in two doses, with an interval of four weeks in age groups 18 and above, reported Anadolu Agency.

The jab has not been advised for pregnant women as available data is “insufficient” to “assess vaccine safety or efficacy in pregnancy.”

Other COVID-19 vaccines approved by the specialised UN agency are Pfizer-BioNTech, Oxford-AstraZeneca, Johnson & Johnson’s Janssen, Moderna, Sinopharm, and Sinovac.

The Phase 3 trials ran from Nov 16, 2020 until May 17, 2021, and included participants between 18 and 97 years old, said the article in the scientific journal.

Trial participants were given two doses of either Covaxin or a placebo.

Participants considered at high risk for COVID-19 infection were prioritised, with 2,750 participants above 60 years of age and 5,724 participants with at least one preexisting condition included in the study.

Participants were recruited from 25 hospitals across India for geographic diversity.

Covaxin “was well-tolerated by all trial participants; 12 per cent of both groups reported an adverse event, with no significant difference in the number of events between the placebo and BBV152 groups,” said the findings.

Sources: BERNAMA

Adib Mohd

Recent Posts

Your September–October Watchlist: Food, Drama & Frights

Mark your calendars, TV junkies. September & October are serving drama, food wars, and spooky… Read More

6 hours ago

Pandora Talisman Drops, Ancient Coin Energy Meets Modern Vibes

Pandora is flipping the script this autumn with the launch of Pandora Talisman, a jewellery… Read More

8 hours ago

LADA Unveils ‘Langkawi Special Deals’ with MAG Partnership to Supercharge Island Tourism

The Langkawi Development Authority (LADA) has launched “Langkawi Special Deals”, a strategic tourism campaign featuring… Read More

8 hours ago

Maxim Rolls Out Partner-Driver Legalization Program to Elevate Compliance and Road Safety

Maxim, one of Malaysia’s leading e-hailing platforms, has officially introduced a Partner-Driver Legalization Program designed… Read More

9 hours ago

Sabah Crowned Malaysia’s Favourite Destination, A Paradise of Peaks, Seas, and Culture Awaits!

Sabah, located in the north-eastern part of Borneo, has officially earned the title of Malaysia’s… Read More

9 hours ago

Coca‑Cola Brings Back ‘Share a Coke’ Now With a Proudly Malaysian Twist

This Merdeka, Coca‑Cola is turning up the nostalgia and the local flavour. The iconic ‘Share… Read More

1 day ago

This website uses cookies.